Phibro Animal Health Corporation Reports First Quarter Results, Revised Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Phibro Animal Health (PAHC) Misses Q1 EPS by 6c; Offers FY23 Guidance
November 9, 2022 4:58 PM ESTPhibro Animal Health (NASDAQ: PAHC) reported Q1 EPS of $0.21, $0.06 worse than the analyst estimate of $0.27. Revenue for the quarter came in at $232.5 million versus the consensus estimate of $221.5 million.
GUIDANCE:
Phibro Animal Health sees FY2023 EPS of $1.21-$1.31, versus the... More
